This proposal stems from our previous studies examining molecular mechanisms by which HIV and FeLV injure cells. Our studies on FeLV have implicated the viral envelope glycoprotein in cell injury, as have others with HIV, and our work has indicated that HIV perturbs cellular membrane functions, causing influx of ions, and shutdown of phospholipid synthesis. Based on these results, we have begun preliminary studies of methods to counter the biochemical insults induced by HIV, and have found that agents which enhance phospholipid synthesis act to protect the infected cell. We feel that development of such a therapy which acts to heal or protect the infected cell rather than to cripple the virus may be useful clinically. Such a therapy used in combination with antiviral agents could potentially prove to be very beneficial to AIDS patients.
The aims of this proposal are to continue our basic studies on how HIV injure cells, focusing on examining enzymatic steps and ribonucleotide levels important in the lipid biosynthetic pathways, to test in HIV cytotoxicity and immunosuppression assays in vitro candidate therapeutic compounds which may reduce cellular membrane damage and/or enhance phospholipid synthesis, and to perform parallel studies with FeLV cytotoxicity and immunosuppression in vitro to determine if the same biochemical lesions occur in that system, and if so, if the compounds protect (as a prelude to in vivo testing in cats).

Project Start
1987-09-30
Project End
1990-08-31
Budget Start
1989-09-01
Budget End
1990-08-31
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
Schools of Medicine
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Atkinson, E A; Barry, M; Darmon, A J et al. (1998) Cytotoxic T lymphocyte-assisted suicide. Caspase 3 activation is primarily the result of the direct action of granzyme B. J Biol Chem 273:21261-6
McDougall, A S; Terry, A; Tzavaras, T et al. (1994) Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses. J Virol 68:2151-60
Miller, M A; Mietzner, T A; Cloyd, M W et al. (1993) Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein. AIDS Res Hum Retroviruses 9:1057-66
Rigby, M A; Rojko, J L; Stewart, M A et al. (1992) Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. J Gen Virol 73 ( Pt 11):2839-47
Rezanka, L J; Rojko, J L; Neil, J C (1992) Feline leukemia virus: pathogenesis of neoplastic disease. Cancer Invest 10:371-89
Rojko, J L; Fulton, R M; Rezanka, L J et al. (1992) Lymphocytotoxic strains of feline leukemia virus induce apoptosis in feline T4-thymic lymphoma cells. Lab Invest 66:418-26
Race, E M; Ramsey, K M; Lucia, H L et al. (1991) Human immunodeficiency virus infection elicits early antibody not detected by standard tests: implications for diagnostics and viral immunology. Virology 184:716-22
Rojko, J L; Kociba, G J (1991) Pathogenesis of infection by the feline leukemia virus. J Am Vet Med Assoc 199:1305-10
Williams, L M; Cloyd, M W (1991) Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology 184:723-8
Tochikura, T S; Hayes, K A; Cheney, C M et al. (1990) In vitro replication and cytopathogenicity of the feline immunodeficiency virus for feline T4 thymic lymphoma 3201 cells. Virology 179:492-7

Showing the most recent 10 out of 14 publications